AKT1 and cancer: It downregulates multiple signaling pathways, such as NF-κB and PI3K/AKT/mTOR, and decreases the expression of downstream cancer genes, including antiapoptotic genes, VEGF, c-met, cyclins, Cdks, and proinflammatory cytokines [207].